Close Menu

Precipio

Transgenomic said this week that Mark Colonnese has resigned as CFO and executive VP effective October 30, 2014. Transgenomics President and CEO Paul Kinnon will assume the role of interim CFO.

NEW YORK (GenomeWeb) — Transgenomic reported today that its third quarter revenues declined 3 percent year over year due to a decrease in sales in both its laboratory services and genetic assays and platform segments.

Nabsys said that Anthony Shuber has joined the company as vice president and chief scientific officer. He comes to Nabsys from Ignyta, an oncology precision medicine firm, where he served as chief technology officer.

NEW YORK (GenomeWeb) — Researchers at the University of Pittsburgh Medical Center have received funding to begin translating animal studies linking environmental toxin exposure and Parkinson's disease pathology to human samples.

NEW YORK (GenomeWeb) — Transgenomic said after the close of the market on Wednesday that its second quarter revenues declined 7 percent year over year.

NEW YORK (GenomeWeb) – Transgenomic today announced an agreement to sell the rights to it Surveyor Nuclease technology and assets to Integrated DNA Technologies for a minimum of $4.25 million.

NEW YORK (GenomeWeb) — Transgenomic said today that it has signed a licensing deal with the Dana-Farber Cancer Institute for exclusive worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCR technology.

NEW YORK (GenomeWeb News) — Transgenomic said after the close of the market on Wednesday that its first quarter revenues declined 15 percent year over year.

NEW YORK (GenomeWeb) – Transgenomic today said that its common shares have been approved for uplisting to the Nasdaq Capital Market.

Researchers affiliated with the laboratory of Mike Makrigiorgos at Dana Farber Cancer Institute and Harvard Medical School have demonstrated how their COLD-PCR method can be applied to epigenetics, allowing the enrichment and sequencing of rare unmethylated DNA regions in a background of highly m

Pages

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.